Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 8/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 5/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10439544 | 1.00 | MAPK1 (0.61) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL12202811 | 0.91 | TSHR (0.68) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL195530 | 0.87 | SMN1; SMN2 (0.71) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL29502789 | 0.87 | SMN1; SMN2 (0.71) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL11810775 | 0.87 | HSP90AA1 (0.55) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL13299337 | 0.87 | KMT2A (0.49) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL14112069 | 0.85 | ALDH1A1 (0.76) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL1245326 | 0.85 | HSD17B10 (0.50) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL19558500 | 0.83 | KMT2A (0.55) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL29990554 | 0.83 | KMT2A (0.55) | MAPK1SMN1; SMN2ALDH1A1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8147931-B2 | Cellulose-film modifier, cellulose composition, and optical cellulose film, polarizing plate-protecting film, polarizing plate, and liquid crystal display device, produced by using the same | FUJIFILM CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20090046225-A1 | OPTICAL FILM, AND POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090029073-A1 | CELLULOSE-FILM MODIFIER, CELLULOSE COMPOSITION, AND OPTICAL CELLULOSE FILM, POLARIZING PLATE-PROTECTING FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE, PRODUCED BY USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090029073-A1 | CELLULOSE-FILM MODIFIER, CELLULOSE COMPOSITION, AND OPTICAL CELLULOSE FILM, POLARIZING PLATE-PROTECTING FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE, PRODUCED BY USING THE SAME | C1QBP, C1R, C1S | MAPK1 1966/4885SMN1; SMN2 4171/4885ALDH1A1 3603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.